| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2006;114:e536.)
© 2006 American Heart Association, Inc.
Correspondence |
Department of Pharmacological Sciences, Medical School, University of Tampere, Tampere, Finland, tuomo.nieminen{at}iki.fi
Department of Clinical Physiology, Tampere University Hospital and Medical School, University of Tampere, Tampere, Finland
The interesting article by Williams et al1 convincingly shows that treatments based on atenolol and amlodipine differ substantially in their influences on central aortic pressures even in long-term treatment, despite having similar effects on brachial blood pressures. The authors conclude that this phenomenon is due to differences in the timing of systolic ejection caused by lower heart rate during treatment with the ß-blocker atenolol. This mechanism certainly has merit.
However, there is another physiological and pharmacological factor to be considered: Because a ß-blocker slows down heart rate, the filling time of the left ventricle increases, leading to larger end-diastolic volume and preload. According to the Frank-Starling law, the higher the preload, the larger the stroke volume (SV). This suggests that ß-blocker therapy would increase SV. This has indeed been demonstrated particularly in using ß-blockers with vasodilatory propertiessuch as nebivolol2 or carvedilol3but also using, for example, atenolol4 and metoprolol.3 Therefore, the enhancement of SV occurs despite the slightly negative inotropic effect of the ß-blockers.
On the other hand, SV is a well-known determinant of pulse pressure (PP)5: Given a constant compliance, elevation of PP is secondary to a rise in SV and vice versa. In the case of atenolol and the consequential increase in SV, the increase in central aortic PP and the changes in the corresponding pressure waveform are probably a combination of the enhanced direct outflow from the heart and stronger reflected pressure waves. We believe that this simple mechanism partially explains the differential effect of amlodipine and atenolol on aortic pressures.
| Acknowledgments |
|---|
None.
| References |
|---|
|
|
|---|
2. Cockcroft J. Nebivolol: a review. Expert Opin Pharmacother. 2004; 5: 893899.[CrossRef][Medline] [Order article via Infotrieve]
3. Metra M, Giubbini R, Nodari S, Boldi E, Modena MG, Dei Cas L. Differential effects of beta-blockers in patients with heart failure: a prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol. Circulation. 2000; 102: 546551.
4. Mier CM, Domenick MA, Wilmore JH. Changes in stroke volume with beta-blockade before and after 10 days of exercise training in men and women. J Appl Physiol. 1997; 83: 16601665.
5. Dart AM, Kingwell BA. Pulse pressure: a review of mechanisms and clinical relevance. J Am Coll Cardiol. 2001; 37: 975984.
Related Article:
Circulation 2006 114: 1555.
This article has been cited by other articles:
![]() |
C. H. Manisty, A. Zambanini, K. H. Parker, J. E. Davies, D. P. Francis, J. Mayet, S. A. McG Thom, A. D. Hughes, and on behalf of the Anglo-Scandinavian Cardiac Outcom Differences in the Magnitude of Wave Reflection Account for Differential Effects of Amlodipine- Versus Atenolol-Based Regimens on Central Blood Pressure: An Anglo-Scandinavian Cardiac Outcome Trial Substudy Hypertension, October 1, 2009; 54(4): 724 - 730. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |